Last 12 months
Inside the activity.
1 purchase rows · 19 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 13 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 03, 2026 Filed Sep 8, 2026 20:29 UTC |
Neville EverettSee Remarks
|
SaleCommon Stock, $.01 Par Value | 617 | $284.05 | $175,258.85 |
DisclosureSEC source: 0001641142-26-000003 · wk-form4_1788899344.xml · nonDerivative · entry 1 Neville Everett · CIK 0001641142 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,053 F1 · acquired: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2026. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:21 UTC |
Evanko Brian CSee Remarks
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 6,716 | $0.00 Strike: $281.13 | $0.00 |
DisclosureSEC source: 0001722909-26-000007 · wk-form4_1788466902.xml · derivative · entry 4 Evanko Brian C · CIK 0001722909 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,716 Underlying: Common Stock, $0.01 Par Value · 6,716 shares Expires 2037-09-01 F3 · derivative.exercise_date: This option vests in three equal annual installments beginning September 1, 2027. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:21 UTC |
Evanko Brian CSee Remarks
|
GrantCommon Stock, $.01 Par Value | 3,113 | $0.00 | $0.00 |
DisclosureSEC source: 0001722909-26-000007 · wk-form4_1788466902.xml · nonDerivative · entry 1 Evanko Brian C · CIK 0001722909 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,030 F1 · shares: These restricted shares vest in three equal annual installments beginning September 1, 2027. Read SEC document |
| August 31, 2026 Filed Sep 2, 2026 20:23 UTC |
Kurian GeorgeDirector
|
GrantPhantom Stock Units · Derivative | 108.6642 | $276.08 | $30,000.01 |
DisclosureSEC source: 0001586813-26-000006 · wk-form4_1788380624.xml · derivative · entry 1 Kurian George · CIK 0001586813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,041.8523 Underlying: Common Stock, $.01 Par Value · 108.6642 shares Expires not disclosed F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash. F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash. F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash. F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash. F2 · ownership.direct: Includes 10.7387 phantom stock units acquired pursuant to a dividend reinvestment feature of the Deferral Plan. Read SEC document |
| August 18, 2026 Filed Aug 20, 2026 21:07 UTC |
Jones Nicole SSee Remarks
|
SaleCommon Stock, $.01 Par Value | 2,677 | $279.61 | $748,515.97 |
DisclosureSEC source: 0001492663-26-000003 · wk-form4_1787260034.xml · nonDerivative · entry 1 Jones Nicole S · CIK 0001492663 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,880 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2026. Read SEC document |
| August 06, 2026 Filed Aug 20, 2026 21:13 UTC |
Holgerson BryanSee Remarks
|
GrantPhantom Stock Units · Derivative | 0.9837 | $275.25 | $270.76 |
DisclosureSEC source: 0002142615-26-000003 · wk-form4_1787260436.xml · derivative · entry 4 Holgerson Bryan · CIK 0002142615 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 944.6253 Underlying: Common Stock, $.01 Par Value · 0.9837 shares Expires not disclosed F2 · derivative.exercise_price: Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash in accordance with the terms of The Cigna Group Executive Deferred Compensation Plan. The reporting person may transfer his interests in The Cigna Group stock fund into an alternative investment fund. F2 · derivative.exercise_date: Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash in accordance with the terms of The Cigna Group Executive Deferred Compensation Plan. The reporting person may transfer his interests in The Cigna Group stock fund into an alternative investment fund. F2 · derivative.expiration_date: Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash in accordance with the terms of The Cigna Group Executive Deferred Compensation Plan. The reporting person may transfer his interests in The Cigna Group stock fund into an alternative investment fund. Read SEC document |
| August 05, 2026 Filed Aug 6, 2026 20:31 UTC |
Jones Nicole SSee Remarks
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,301 | $0.00 Strike: $192.02 | $0.00 |
DisclosureSEC source: 0001739940-26-000067 · wk-form4_1786048270.xml · derivative · entry 6 Jones Nicole S · CIK 0001492663 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.01 Par Value · 1,301 shares Expires 2030-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2026. F3 · derivative.exercise_date: This option was granted on February 26, 2020. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date. Read SEC document |
| August 05, 2026 Filed Aug 6, 2026 20:31 UTC |
Jones Nicole SSee Remarks
|
Exercise / conversionCommon Stock, $.01 Par Value | 1,301 | $192.02 | $249,818.02 |
DisclosureSEC source: 0001739940-26-000067 · wk-form4_1786048270.xml · nonDerivative · entry 3 Jones Nicole S · CIK 0001492663 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,557 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2026. Read SEC document |
| August 04, 2026 Filed Aug 6, 2026 20:31 UTC |
Jones Nicole SSee Remarks
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 14,045 | $0.00 Strike: $192.02 | $0.00 |
DisclosureSEC source: 0001739940-26-000067 · wk-form4_1786048270.xml · derivative · entry 5 Jones Nicole S · CIK 0001492663 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,301 Underlying: Common Stock, $.01 Par Value · 14,045 shares Expires 2030-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2026. F3 · derivative.exercise_date: This option was granted on February 26, 2020. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date. Read SEC document |
| August 04, 2026 Filed Aug 6, 2026 20:31 UTC |
Jones Nicole SSee Remarks
|
SaleCommon Stock, $.01 Par Value | 19,436 | $276.27 | $5,369,583.72 |
DisclosureSEC source: 0001739940-26-000067 · wk-form4_1786048270.xml · nonDerivative · entry 2 Jones Nicole S · CIK 0001492663 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,256 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2026. Read SEC document |
| August 04, 2026 Filed Aug 6, 2026 20:31 UTC |
Jones Nicole SSee Remarks
|
Exercise / conversionCommon Stock, $.01 Par Value | 14,045 | $192.02 | $2,696,920.90 |
DisclosureSEC source: 0001739940-26-000067 · wk-form4_1786048270.xml · nonDerivative · entry 1 Jones Nicole S · CIK 0001492663 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 46,692 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2026. Read SEC document |
| July 23, 2026 Filed Aug 20, 2026 21:13 UTC |
Holgerson BryanSee Remarks
|
GrantPhantom Stock Units · Derivative | 0.9458 | $286.29 | $270.77 |
DisclosureSEC source: 0002142615-26-000003 · wk-form4_1787260436.xml · derivative · entry 3 Holgerson Bryan · CIK 0002142615 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 943.6416 Underlying: Common Stock, $.01 Par Value · 0.9458 shares Expires not disclosed F2 · derivative.exercise_price: Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash in accordance with the terms of The Cigna Group Executive Deferred Compensation Plan. The reporting person may transfer his interests in The Cigna Group stock fund into an alternative investment fund. F2 · derivative.exercise_date: Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash in accordance with the terms of The Cigna Group Executive Deferred Compensation Plan. The reporting person may transfer his interests in The Cigna Group stock fund into an alternative investment fund. F2 · derivative.expiration_date: Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash in accordance with the terms of The Cigna Group Executive Deferred Compensation Plan. The reporting person may transfer his interests in The Cigna Group stock fund into an alternative investment fund. Read SEC document |
| July 09, 2026 Filed Aug 20, 2026 21:13 UTC |
Holgerson BryanSee Remarks
|
GrantPhantom Stock Units · Derivative | 0.8873 | $291.80 | $258.91 |
DisclosureSEC source: 0002142615-26-000003 · wk-form4_1787260436.xml · derivative · entry 2 Holgerson Bryan · CIK 0002142615 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 942.6958 Underlying: Common Stock, $.01 Par Value · 0.8873 shares Expires not disclosed F2 · derivative.exercise_price: Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash in accordance with the terms of The Cigna Group Executive Deferred Compensation Plan. The reporting person may transfer his interests in The Cigna Group stock fund into an alternative investment fund. F2 · derivative.exercise_date: Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash in accordance with the terms of The Cigna Group Executive Deferred Compensation Plan. The reporting person may transfer his interests in The Cigna Group stock fund into an alternative investment fund. F2 · derivative.expiration_date: Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash in accordance with the terms of The Cigna Group Executive Deferred Compensation Plan. The reporting person may transfer his interests in The Cigna Group stock fund into an alternative investment fund. Read SEC document |
| June 12, 2026 Filed Jun 16, 2026 21:05 UTC |
Kates Jamie GChief Accounting Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 899 | $0.00 Strike: $152.89 | $0.00 |
DisclosureSEC source: 0001739940-26-000047 · wk-form4_1781643916.xml · derivative · entry 3 Kates Jamie G · CIK 0002029677 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.01 Par Value · 899 shares Expires 2028-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option was granted on February 28, 2018. The option vested in three equal annual installments starting on February 28, 2019. Read SEC document |
| June 12, 2026 Filed Jun 16, 2026 21:05 UTC |
Kates Jamie GChief Accounting Officer
|
SaleCommon Stock, $.01 Par Value | 899 | $298.61 | $268,452.19 |
DisclosureSEC source: 0001739940-26-000047 · wk-form4_1781643916.xml · nonDerivative · entry 2 Kates Jamie G · CIK 0002029677 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,368 Read SEC document |
| June 12, 2026 Filed Jun 16, 2026 21:05 UTC |
Kates Jamie GChief Accounting Officer
|
Exercise / conversionCommon Stock, $.01 Par Value | 899 | $152.89 | $137,452.34 |
DisclosureSEC source: 0001739940-26-000047 · wk-form4_1781643916.xml · nonDerivative · entry 1 Kates Jamie G · CIK 0002029677 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,267 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:16 UTC |
Koka Durga PrasadEVP, Global CIO
|
Tax withholdingCommon Stock, $.01 Par Value | 729 | $275.53 | $200,861.37 |
DisclosureSEC source: 0001739940-26-000045 · wk-form4_1780517774.xml · nonDerivative · entry 1 Koka Durga Prasad · CIK 0002086071 · EVP, Global CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,552 F1 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 21:13 UTC |
Kurian GeorgeDirector
|
GrantPhantom Stock Units · Derivative | 108.1471 | $277.40 | $30,000.01 |
DisclosureSEC source: 0001586813-26-000004 · wk-form4_1780434804.xml · derivative · entry 1 Kurian George · CIK 0001586813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,922.4494 Underlying: Common Stock, $.01 Par Value · 108.1471 shares Expires not disclosed F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash. F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash. F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash. F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash. F2 · ownership.direct: Includes 10.6351 phantom stock units acquired pursuant to a dividend reinvestment feature of the Deferral Plan. Read SEC document |
| May 13, 2026 Filed May 14, 2026 20:47 UTC |
Cordani DavidDirector · Chairman & CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,971 | $0.00 Strike: $197.35 | $0.00 |
DisclosureSEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · derivative · entry 24 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.01 Par Value · 7,971 shares Expires 2028-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F17 · shares: This option was granted on February 28, 2018. The option vested in three equal annual installments starting on March 1, 2019. Read SEC document |
| May 13, 2026 Filed May 14, 2026 20:47 UTC |
Cordani DavidDirector · Chairman & CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 15,458 | $0.00 Strike: $149.14 | $0.00 |
DisclosureSEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · derivative · entry 22 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.01 Par Value · 15,458 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F16 · shares: This option was granted on February 28, 2017. The option vested in three equal annual installments starting on March 1, 2018. Read SEC document |
| May 13, 2026 Filed May 14, 2026 20:47 UTC |
Cordani DavidDirector · Chairman & CEO
|
Exercise / conversionCommon Stock, $.01 Par Value | 7,971 | $197.35 | $1,573,076.85 |
DisclosureSEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 17 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 57,766 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. Read SEC document |
| May 13, 2026 Filed May 14, 2026 20:47 UTC |
Cordani DavidDirector · Chairman & CEO
|
Exercise / conversionCommon Stock, $.01 Par Value | 15,458 | $149.14 | $2,305,328.83 |
DisclosureSEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 16 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. Read SEC document |
| May 12, 2026 Filed May 14, 2026 20:47 UTC |
Cordani DavidDirector · Chairman & CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 85,519 | $0.00 Strike: $197.35 | $0.00 |
DisclosureSEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · derivative · entry 23 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,971 Underlying: Common Stock, $.01 Par Value · 85,519 shares Expires 2028-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F17 · shares: This option was granted on February 28, 2018. The option vested in three equal annual installments starting on March 1, 2019. Read SEC document |
| May 12, 2026 Filed May 14, 2026 20:47 UTC |
Cordani DavidDirector · Chairman & CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 103,595 | $0.00 Strike: $149.14 | $0.00 |
DisclosureSEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · derivative · entry 21 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,458 Underlying: Common Stock, $.01 Par Value · 103,595 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F16 · shares: This option was granted on February 28, 2017. The option vested in three equal annual installments starting on March 1, 2018. Read SEC document |
| May 12, 2026 Filed May 14, 2026 20:47 UTC |
Cordani DavidDirector · Chairman & CEO
|
SaleCommon Stock, $.01 Par Value | 2,231 | $298.53 | $666,026.68 |
DisclosureSEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 15 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,337 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F14 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $298.495 to $298.675 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 12, 2026 Filed May 14, 2026 20:47 UTC |
Cordani DavidDirector · Chairman & CEO
|
SaleCommon Stock, $.01 Par Value | 15,319 | $298.24 | $4,568,735.50 |
DisclosureSEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 14 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,568 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F13 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $297.492 to $298.49 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 12, 2026 Filed May 14, 2026 20:47 UTC |
Cordani DavidDirector · Chairman & CEO
|
SaleCommon Stock, $.01 Par Value | 2,017 | $296.84 | $598,717.61 |
DisclosureSEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 13 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,887 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F12 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $296.46 to $297.45 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 12, 2026 Filed May 14, 2026 20:47 UTC |
Cordani DavidDirector · Chairman & CEO
|
SaleCommon Stock, $.01 Par Value | 34,641 | $295.98 | $10,253,195.60 |
DisclosureSEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 12 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,904 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F11 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $295.46 to $296.45 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 12, 2026 Filed May 14, 2026 20:47 UTC |
Cordani DavidDirector · Chairman & CEO
|
SaleCommon Stock, $.01 Par Value | 38,487 | $294.98 | $11,352,887.56 |
DisclosureSEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 11 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 88,545 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F10 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $294.46 to $295.453 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 12, 2026 Filed May 14, 2026 20:47 UTC |
Cordani DavidDirector · Chairman & CEO
|
SaleCommon Stock, $.01 Par Value | 2,142 | $293.92 | $629,574.50 |
DisclosureSEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 10 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 127,032 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F9 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $293.46 to $294.45 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 12, 2026 Filed May 14, 2026 20:47 UTC |
Cordani DavidDirector · Chairman & CEO
|
SaleCommon Stock, $.01 Par Value | 7,861 | $292.88 | $2,302,310.81 |
DisclosureSEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 9 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 129,174 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F8 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $292.44 to $293.435 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 12, 2026 Filed May 14, 2026 20:47 UTC |
Cordani DavidDirector · Chairman & CEO
|
SaleCommon Stock, $.01 Par Value | 12,315 | $291.95 | $3,595,313.76 |
DisclosureSEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 8 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 137,035 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F7 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $291.44 to $292.435 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 12, 2026 Filed May 14, 2026 20:47 UTC |
Cordani DavidDirector · Chairman & CEO
|
SaleCommon Stock, $.01 Par Value | 13,732 | $291.01 | $3,996,088.90 |
DisclosureSEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 7 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 149,350 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F6 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $290.44 to $291.438 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 12, 2026 Filed May 14, 2026 20:47 UTC |
Cordani DavidDirector · Chairman & CEO
|
SaleCommon Stock, $.01 Par Value | 41,099 | $290.00 | $11,918,783.98 |
DisclosureSEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 6 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 163,082 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F5 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $289.435 to $290.43 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 12, 2026 Filed May 14, 2026 20:47 UTC |
Cordani DavidDirector · Chairman & CEO
|
SaleCommon Stock, $.01 Par Value | 13,839 | $288.85 | $3,997,456.04 |
DisclosureSEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 5 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 204,181 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F4 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $288.435 to $289.41 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 12, 2026 Filed May 14, 2026 20:47 UTC |
Cordani DavidDirector · Chairman & CEO
|
SaleCommon Stock, $.01 Par Value | 14,292 | $287.96 | $4,115,590.06 |
DisclosureSEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 4 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 218,020 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F3 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $287.43 to $288.42 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 12, 2026 Filed May 14, 2026 20:47 UTC |
Cordani DavidDirector · Chairman & CEO
|
SaleCommon Stock, $.01 Par Value | 3,903 | $286.83 | $1,119,505.30 |
DisclosureSEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 3 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 232,312 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F2 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $286.43 to $287.425 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 12, 2026 Filed May 14, 2026 20:47 UTC |
Cordani DavidDirector · Chairman & CEO
|
Exercise / conversionCommon Stock, $.01 Par Value | 85,519 | $197.35 | $16,877,174.65 |
DisclosureSEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 2 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 236,215 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. Read SEC document |
| May 12, 2026 Filed May 14, 2026 20:47 UTC |
Cordani DavidDirector · Chairman & CEO
|
Exercise / conversionCommon Stock, $.01 Par Value | 103,595 | $149.14 | $15,449,640.33 |
DisclosureSEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 1 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 150,696 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:48 UTC |
Ozuah PhilipDirector
|
GrantCommon Stock, $.01 Par Value | 782 | $0.00 | $0.00 |
DisclosureSEC source: 0001739940-26-000029 · wk-form4_1777063690.xml · nonDerivative · entry 1 Ozuah Philip · CIK 0001859685 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,583 Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:58 UTC |
Hathi NeeshaDirector
|
GrantCommon Stock, $.01 Par Value | 782 | $0.00 | $0.00 |
DisclosureSEC source: 0001739940-26-000035 · wk-form4_1777064282.xml · nonDerivative · entry 1 Hathi Neesha · CIK 0001879974 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,151 Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:58 UTC |
McClellan Mark B.Director
|
GrantCommon Stock, $.01 Par Value | 782 | $0.00 | $0.00 |
DisclosureSEC source: 0001739940-26-000036 · wk-form4_1777064329.xml · nonDerivative · entry 1 McClellan Mark B. · CIK 0001567006 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,891 Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:59 UTC |
FOSS ERIC JDirector
|
GrantCommon Stock, $.01 Par Value | 782 | $0.00 | $0.00 |
DisclosureSEC source: 0001739940-26-000037 · wk-form4_1777064356.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,696 Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:57 UTC |
ZARCONE DONNA FDirector
|
GrantCommon Stock, $.01 Par Value | 782 | $0.00 | $0.00 |
DisclosureSEC source: 0001739940-26-000034 · wk-form4_1777064252.xml · nonDerivative · entry 1 ZARCONE DONNA F · CIK 0001243083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,517 F1 · balance_after: The reporting person's economic interest in The Cigna Group securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of The Cigna Group stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than The Cigna Group stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for The Cigna Group and pages 51-52 and 118 of The Cigna Group's proxy statement filed with the SEC on March 13, 2026. Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:53 UTC |
MAZZARELLA KATHLEEN MDirector
|
GrantCommon Stock, $.01 Par Value | 782 | $0.00 | $0.00 |
DisclosureSEC source: 0001739940-26-000033 · wk-form4_1777064036.xml · nonDerivative · entry 1 MAZZARELLA KATHLEEN M · CIK 0001273233 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,891 Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:53 UTC |
Kurian GeorgeDirector
|
GrantCommon Stock, $.01 Par Value | 782 | $0.00 | $0.00 |
DisclosureSEC source: 0001739940-26-000032 · wk-form4_1777063983.xml · nonDerivative · entry 1 Kurian George · CIK 0001586813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,560 F1 · balance_after: The reporting person's economic interest in The Cigna Group securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of The Cigna Group stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than The Cigna Group stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for The Cigna Group and pages 51-52 and 118 of The Cigna Group's proxy statement filed with the SEC on March 13, 2026. Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:51 UTC |
Ross Kimberly A.Director
|
GrantCommon Stock, $.01 Par Value | 782 | $0.00 | $0.00 |
DisclosureSEC source: 0001739940-26-000031 · wk-form4_1777063857.xml · nonDerivative · entry 1 Ross Kimberly A. · CIK 0001536350 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,294 Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:49 UTC |
Hennigan Michael JDirector
|
GrantCommon Stock, $.01 Par Value | 782 | $0.00 | $0.00 |
DisclosureSEC source: 0001739940-26-000030 · wk-form4_1777063790.xml · nonDerivative · entry 1 Hennigan Michael J · CIK 0001352283 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,350 Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:47 UTC |
WISEMAN ERIC CDirector
|
GrantCommon Stock, $.01 Par Value | 782 | $0.00 | $0.00 |
DisclosureSEC source: 0001739940-26-000028 · wk-form4_1777063639.xml · nonDerivative · entry 1 WISEMAN ERIC C · CIK 0001237851 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,940 F1 · balance_after: The reporting person's economic interest in The Cigna Group securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of The Cigna Group stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than The Cigna Group stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for The Cigna Group and pages 51-52 and 118 of The Cigna Group's proxy statement filed with the SEC on March 13, 2026. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 00:18 UTC |
Neville EverettSee Remarks
|
SaleCommon Stock, $.01 Par Value | 1,719 | $288.91 | $496,636.29 |
DisclosureSEC source: 0001739940-26-000016 · wk-form4_1772583534.xml · nonDerivative · entry 5 Neville Everett · CIK 0001641142 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,670 F5 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.